OptiNose
ID: 5290746A pharmaceutical company focused developing products for diseases treated by ear, nose, and throat (ENT) and allergy specialists
2
Funding Rounds
$48.5m
Money raised
Recent Funding Rounds
Overview
A pharmaceutical company focused developing products for diseases treated by ear, nose, and throat (ENT) and allergy specialists
- Website:
- Business model: B2B
- Headquarters: Yardley, Pennsylvania
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Pe*** K. Mi**** | - | - | |
| Er** Be******* | - | - | - |
| Jo** Fl****** (e************ | - | - | - |
| Jo**** C. Sc***** | - | - | - |
| Wi******* Gr********* | - | - | - |
| Sa**** L. He**** | - | - | - |
| To*** J. He**** | - | - | - |
Funding series
Funding Series Analysis
The company OptiNose has raised a total of $48.5m in funding over 2 rounds.
Key Insights:
- OptiNose funding round, June 2010: $48.5m
Industries
OptiNose is active in the following industries: